U.S. officials said on Sunday that air strikes in Iraq and Syria against an Iran-backed militia group were successful, but warned that “additional actions” may still be taken in the region to defend U.S. interests.

The U.S. military carried out the strikes on Sunday against the Kataib Hezbollah militia group in response to the killing of a U.S. civilian contractor in a rocket attack on an Iraqi military base, officials said.

U.S. President Donald Trump was briefed by his top national security advisers following the strikes at his Mar-a-Lago club in Palm Beach, Florida.

“We will not stand for the Islamic Republic of Iran to take actions that put American men and women in jeopardy,” U.S. Secretary of State Mike Pompeo told reporters after the briefing with Trump.

Pompeo, Defense Secretary Mark Esper and General Mark Milley, chairman of the U.S. Joint Chiefs of Staff, appeared briefly in a club ballroom to comment on the airstrikes.

Esper termed the offensive “successful,” but said that Trump was informed that a further military response could be warranted.

“We discussed with him other options that are available,” Esper said. “I would note also that we will take additional actions as necessary to ensure that we act in our own self-defense and we deter further bad behavior from militia groups or from Iran.”

Iraqi security and militia sources said at least 25 militia fighters were killed and at least 55 wounded following three U.S. air strikes in Iraq on Sunday.

At least four local Kataib Hezbollah commanders were among the dead, the sources said, adding that one of the strikes had targeted the militia group’s headquarters near the western Qaim district on the border with Syria.

The Pentagon said it had targeted three locations of the Iranian-backed Shi’ite Muslim militia group in Iraq and two in Syria. The locations included weapons storage facilities and command and control locations the group had used to plan and execute attacks on coalition forces, it said. Read more

Read also:Rep. John Lewis Diagnosed With Stage 4 Pancreatic Cancer